Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion type Assertion NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_head.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion description "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion evidence source_evidence_literature NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion SIO_000772 18444168 NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion wasDerivedFrom befree-20140225 NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion wasGeneratedBy ECO_0000203 NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.